The microbiome–cancer axis as a hidden contributor to early-onset tumorigenesis

Ben-Aharon I, van Laarhoven HWM, Fontana E, Obermannova R, Nilsson M, Lordick F. Early-onset cancer in the gastrointestinal tract is on the rise-evidence and implications. Cancer Discov. 2023;13:538–51. https://doi.org/10.1158/2159-8290.CD-22-1038.

Article  PubMed  CAS  Google Scholar 

Zhao J, Xu L, Sun J, Song M, Wang L, Yuan S, et al. Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019. Bmjonc. 2023;2:e000049. https://doi.org/10.1136/bmjonc-2023-000049.

Article  Google Scholar 

Abualkhair WH, Zhou M, Ahnen D, Yu Q, Wu X-C, Karlitz JJ. Trends in incidence of early-onset colorectal cancer in the United States among those approaching screening age. JAMA Netw Open. 2020;3:e1920407. https://doi.org/10.1001/jamanetworkopen.2019.20407.

Article  PubMed  PubMed Central  Google Scholar 

Terashima M, Lee H-Y, Tsukumo Y, Ugai S, Song M, Sasamoto N, et al. Abstract 4847: diverging global incidence trends of early-onset and later-onset cancers. Cancer Res. 2024;84:4847–4847. https://doi.org/10.1158/1538-7445.AM2024-4847.

Article  Google Scholar 

Kerr J, Anderson C, Lippman SM. Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence. Lancet Oncol. 2017;18:e457–71. https://doi.org/10.1016/S1470-2045(17)30411-4.

Article  Google Scholar 

Marcus PM. Population measures: cancer screening’s impact. Assessment of cancer screening: A primer, Cham: Springer International Publishing; 2022, p. 51–66. https://doi.org/10.1007/978-3-030-94577-0_5.

Mauri G, Patelli G, Sartore-Bianchi A, Abrignani S, Bodega B, Marsoni S, et al. Early-onset cancers: biological bases and clinical implications. Cell Rep Med. 2024;5:101737. https://doi.org/10.1016/j.xcrm.2024.101737.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Owens L, Fung A, Shuhendler J, Glick J, Ryser MD, Gulati R, et al. Trends in young-onset cancer incidence: a modeling perspective. J Natl Cancer Inst. 2025. https://doi.org/10.1093/jnci/djaf050.

Article  PubMed  Google Scholar 

Ugai T, Sasamoto N, Lee H-Y, Ando M, Song M, Tamimi RM, et al. Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nat Rev Clin Oncol. 2022;19:656–73. https://doi.org/10.1038/s41571-022-00672-8.

Article  PubMed  PubMed Central  Google Scholar 

Mima K, Hamada T, Inamura K, Baba H, Ugai T, Ogino S. The microbiome and rise of early-onset cancers: knowledge gaps and research opportunities. Gut Microbes. 2023;15:2269623. https://doi.org/10.1080/19490976.2023.2269623.

Article  PubMed  PubMed Central  Google Scholar 

Atchade AM, Williams JL, Mermelstein L, Nemesure B. Unraveling the complexities of early-onset colorectal cancer: a perspective on dietary and microbial influences. Front Public Health. 2024;12:1370108. https://doi.org/10.3389/fpubh.2024.1370108.

Article  PubMed  PubMed Central  Google Scholar 

Busi SB, Lei Z, Sumner LW, Amos-Landgraf JM. Integrated multi-omic analyses provide insight into colon adenoma susceptibility modulation by the gut microbiota. mSystems. 2023;8:e0015123. https://doi.org/10.1128/msystems.00151-23.

Article  PubMed  CAS  Google Scholar 

Qiu Q, Lin Y, Ma Y, Li X, Liang J, Chen Z, et al. Exploring the emerging role of the gut microbiota and tumor microenvironment in cancer immunotherapy. Front Immunol. 2020;11:612202. https://doi.org/10.3389/fimmu.2020.612202.

Article  PubMed  CAS  Google Scholar 

Xu Z, Lv Z, Chen F, Zhang Y, Xu Z, Huo J, et al. Dysbiosis of human tumor microbiome and aberrant residence of Actinomyces in tumor-associated fibroblasts in young-onset colorectal cancer. Front Immunol. 2022;13:1008975. https://doi.org/10.3389/fimmu.2022.1008975.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Roelands J, Ploeg M van der, Dang H, Hawinkels L, Morreau H, Miranda N de. 673 (Re-) Solving the biology of colorectal cancer onset and progression to improve treatment and prevention. Regular and Young Investigator Award Abstracts, BMJ Publishing Group Ltd; 2021, p. A701–A701. https://doi.org/10.1136/jitc-2021-SITC2021.673.

Cao C, Yue S, Lu A, Liang C. Host-gut microbiota metabolic interactions and their role in precision diagnosis and treatment of gastrointestinal cancers. Pharmacol Res. 2024;207:107321. https://doi.org/10.1016/j.phrs.2024.107321.

Article  PubMed  CAS  Google Scholar 

M.Phil Health Biotechnology, Department of Biotechnology, Faculty of Chemical and Life Sciences Abdul Wali Khan University Mardan, Pakistan, Nouman M, Humayun F, Department of Biotechnology, Abdul Wali Khan University Mardan, Pakistan, khan SA, Department: Biotechnology and Genetic Engineering, Hazara University Mansehra, Pakistan, et al. Gut Microbiome-Host microRNA Interactions in Cancer Development and Immune Regulation: A Case of Colorectal and Breast Cancer. TAJMSPR 2025;7:6–20. https://doi.org/10.37547/tajmspr/Volume07Issue02-02.

Hamada T, Nowak JA, Milner DA, Song M, Ogino S. Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms. J Pathol. 2019;247:615–28. https://doi.org/10.1002/path.5236.

Article  PubMed  PubMed Central  Google Scholar 

Jayakrishnan T, Sangwan N, Nair KG, Kamath SD, Patel M, Joyce D, et al. Tumor microbiome differences in early-onset versus average-onset pancreatic adenocarcinoma. JCO. 2024;42:4016–4016. https://doi.org/10.1200/JCO.2024.42.16_suppl.4016.

Article  Google Scholar 

Ou S, Wang H, Tao Y, Luo K, Ye J, Ran S, et al. Fusobacterium nucleatum and colorectal cancer: from phenomenon to mechanism. Front Cell Infect Microbiol. 2022;12:1020583. https://doi.org/10.3389/fcimb.2022.1020583.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sepich-Poore GD, Zitvogel L, Straussman R, Hasty J, Wargo JA, Knight R. The microbiome and human cancer. Science. 2021. https://doi.org/10.1126/science.abc4552.

Article  PubMed  PubMed Central  Google Scholar 

Adnan D, Trinh JQ, Sharma D, Alsayid M, Bishehsari F. Early-onset colon cancer shows a distinct intestinal microbiome and a host-microbe interaction. Cancer Prev Res (Phila Pa). 2024;17:29–38. https://doi.org/10.1158/1940-6207.CAPR-23-0091.

Article  CAS  Google Scholar 

Sadrekarimi H, Gardanova ZR, Bakhshesh M, Ebrahimzadeh F, Yaseri AF, Thangavelu L, et al. Emerging role of human microbiome in cancer development and response to therapy: special focus on intestinal microflora. J Transl Med. 2022;20:301. https://doi.org/10.1186/s12967-022-03492-7.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sundin J, Öhman L, Simrén M. Understanding the gut microbiota in inflammatory and functional gastrointestinal diseases. Psychosom Med. 2017;79:857–67. https://doi.org/10.1097/PSY.0000000000000470.

Article  PubMed  CAS  Google Scholar 

Tariq M, Gulzar M, Mir D, Kousar M. The role of the gut microbiome in immune dysregulation and pathogenesis of inflammatory bowel disease: microbial dysbiosis in inflammatory bowel disease. Dev Medico-Life-Sci. 2025;2(1):13–25.

Article  CAS  Google Scholar 

Shaw KA, Bertha M, Hofmekler T, Chopra P, Vatanen T, Srivatsa A, et al. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease. Genome Med. 2016;8:75. https://doi.org/10.1186/s13073-016-0331-y.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Forbes JD, Chen C-Y, Knox NC, Marrie R-A, El-Gabalawy H, de Kievit T, et al. A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist? Microbiome. 2018;6:221. https://doi.org/10.1186/s40168-018-0603-4.

Article  PubMed  PubMed Central  Google Scholar 

Hughes ER, Winter MG, Duerkop BA, Spiga L, de Carvalho TF, Zhu W, et al. Microbial respiration and formate oxidation as metabolic signatures of inflammation-associated Dysbiosis. Cell Host Microbe. 2017;21(2):208–19. https://doi.org/10.1016/j.chom.2017.01.005.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Potrykus M, Czaja-Stolc S, Stankiewicz M, Kaska Ł, Małgorzewicz S. Intestinal microbiota as a contributor to chronic inflammation and its potential modifications. Nutrients. 2021. https://doi.org/10.3390/nu13113839.

Article  PubMed  PubMed Central  Google Scholar 

Peña-Durán E, García-Galindo JJ, López-Murillo LD, Huerta-Huerta A, Balleza-Alejandri LR, Beltrán-Ramírez A, et al. Microbiota and inflammatory markers: a review of their interplay, clinical implications, and metabolic disorders. Ijms. 2025;26:1773. https://doi.org/10.3390/ijms26041773.

Article  PubMed  PubMed Central 

Comments (0)

No login
gif